NCT01317173Unknown不适用
The Impact of FGF23 and Klotho on Progression of Chronic Kidney Disease
Ankara Education and Research Hospital1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2008年3月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 90
- 试验地点
- 1
- 主要终点
- Progression of kidney disease
研究概览
简要总结
Chronic kidney disease is a progressive disorder that has been influenced with many factors. Most of the patients has altered Ca P metabolism and these dis orders are the contributing factors of the disease progression. It has been recently documented that FGF23 and Klotho are the key factors of PTH secretion Ca-P metabolism. This study aimed to evaluate the impact of Klotho and FGF23 on the progression of stage 3-4 chronic kidney disease.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 65 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Non-diabetic chronic kidney disease
排除标准
- •Presence of DM
- •Actively using calcium based phosphorus binder of vitamin D
结局指标
主要结局
Progression of kidney disease
时间窗: continuous measurement of kidney functions 3 monthly for two years or until the outcome reached
Doubling of creatinin, requirement of renal replacement therapy
次要结局
- Evaluation of Ca P metabolism(3 monthly for two years or until the outcome reached)
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
The Role of FGF23 and Asymmetric Dimethylarginine (ADMA) in Chronic Kidney DiseaseMetabolic DiseasesChronic Kidney DiseaseNCT01317186Ankara Education and Research Hospital100
已完成
不适用
New Heart Failure Biomarkers in Early Stage Chronic Kidney Disease-Mineral and Bone DisorderKidney Disease, ChronicHeart FailureNCT03307707Pr. Semir Nouira111
已完成
4 期
Effect of Phosphate Binders on FGF-23 With Concurrent CalcitriolChronic Kidney Disease Stage 3NCT01748396Seoul National University Hospital30
Unknown
不适用
Klotho in Chronic Kidney Disease-associated Pruritis (CKD-aP)Chronic Kidney Disease-associated PruritusNCT03532568Cairo University60
已完成
不适用
The effects of FGF23 and Klotho on vascular calcification in end stage renal disease patients;<br>NL-OMON47072Catharina-ziekenhuis70
